# Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis

> **NCT01222273** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 7 (actual)

## Conditions studied

- Cystic Fibrosis
- Allergic Bronchopulmonary Aspergillosis

## Interventions

- **DIETARY_SUPPLEMENT:** cholecalciferol (Vitamin D3)

## Key facts

- **NCT ID:** NCT01222273
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222273, "Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01222273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*